Fundraising FoxRVL Pharmaceuticals
Bridgewater, US · Incorporated in Ireland · 1 known investors
Find your way into RVL Pharmaceuticals
Sign up to see every warm intro you have to RVL Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RVL Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RVL Pharmaceuticals develops prescription and skincare products for ocular and aesthetic care, including its flagship prescription eye drop Upneeq (oxymetazoline hydrochloride ophthalmic solution) and the Upneeq Reveal Under Eye Complex skincare product. It serves consumers and healthcare providers with tech-enabled access and integrated fulfillment.
Founders & leadership
Investors · 1
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2023
▶$5MraisedAug 2023 · 1 investors · PharmaceuticalsRule 506(b)
- BRIAN MARKISONExecutive Officer, Director
- GREGORY COWANDirector
- JUAN VERGEZDirector
- JOAQUIN BENESDirector
- MICHAEL DEBIASIDirector
- ALISA LASKDirector
- JAMES SCHAUBExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- Sales commissions
- $812.5K
- Placement agents
- H.C. WAINWRIGHT & CO., LLC
- First sale
- Aug 2023
- Incorporated
- Other, Ireland
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as RVL Pharmaceuticals.
Frequently asked questions
- What does RVL Pharmaceuticals do?
- RVL Pharmaceuticals develops prescription and skincare products for ocular and aesthetic care, including its flagship prescription eye drop Upneeq (oxymetazoline hydrochloride ophthalmic solution) and the Upneeq Reveal Under Eye Complex skincare product. It serves consumers and healthcare providers with tech-enabled access and integrated fulfillment.
- Who are RVL Pharmaceuticals's investors?
- RVL Pharmaceuticals's investors include Avista.
- How much funding has RVL Pharmaceuticals raised?
- RVL Pharmaceuticals has disclosed $5M raised across 1 round.
- Where is RVL Pharmaceuticals headquartered?
- RVL Pharmaceuticals is headquartered in Bridgewater, US.